These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5415118)

  • 1. Potent peripheral and splanchnic vasodilator peptide from normal gut.
    Said SI; Mutt V
    Nature; 1970 Feb; 225(5235):863-4. PubMed ID: 5415118
    [No Abstract]   [Full Text] [Related]  

  • 2. A peptide fraction from lung tissue with prolonged peripheral vasodilator activity.
    Said SI; Mutt V
    Scand J Clin Lab Invest Suppl; 1969; 107():51-6. PubMed ID: 5375727
    [No Abstract]   [Full Text] [Related]  

  • 3. Candidate hormones of the gut. V. Vasoactive intestinal peptide (VIP).
    Said SI
    Gastroenterology; 1974 Oct; 67(4):735-7. PubMed ID: 4606296
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenoceptive sites in the veins.
    Zsoter T; Tom H
    Br J Pharmacol Chemother; 1967 Nov; 31(3):407-19. PubMed ID: 4384258
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of ouabain on the splanchnic circulation.
    Harrison LA; Blaschke J; Phillips RS; Price WE; Cotton MD; Jacobson ED
    J Pharmacol Exp Ther; 1969 Oct; 169(2):321-7. PubMed ID: 5824612
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperglycemic and glycogenolytic effects of vasoactive intestinal polypeptide.
    Kerins C; Said SI
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):1014-7. PubMed ID: 4691998
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of gastro-intestinal polypeptides on hepatic bile flow and splanchnic circulation.
    Thulin L
    Acta Chir Scand Suppl; 1973; 441():1-31. PubMed ID: 4520865
    [No Abstract]   [Full Text] [Related]  

  • 8. Splanchnic and cerebral vasodilatory effects of calcitonin gene-related peptide I in humans.
    Mulholland MW; Sarpa MS; Delvalle J; Messina LM
    Ann Surg; 1991 Oct; 214(4):440-5; discussion 446-7. PubMed ID: 1683216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine-like renal and mesenteric vasodilation caused by apomorphine 6-propylnorapomorphine and 2-amino-6, 7-dihydroxy-1,2,3,4-tetrahydronaphthalene.
    Crumly HJ; Pinder RM; Hinshaw WB; Goldberg LI
    Nature; 1976 Feb; 259(5544):584-7. PubMed ID: 1250405
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological activities of synthetic peptides corresponding to fragments of and to the entire sequence of the vasoactive intestinal peptide.
    Bodanszky M; Klausner YS; Said SI
    Proc Natl Acad Sci U S A; 1973 Feb; 70(2):382-4. PubMed ID: 4510282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glucagon on the splanchnic and the systemic circulation.
    Madden JJ; Ludewig RM; Wangensteen SL
    Rev Surg; 1972; 29(5):372-3. PubMed ID: 5069033
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuing studies of the peripheral vascular actions of dopamine.
    Goldberg LI; Tjandramaga TB; Anton AH; Toda N
    Adv Neurol; 1974; 5():165-73. PubMed ID: 4440569
    [No Abstract]   [Full Text] [Related]  

  • 13. An evaluation of the vasodilation produced by mephentermine and certain other sympathomimetic amines.
    Caldwell RW; Goldberg LI
    J Pharmacol Exp Ther; 1970 Apr; 172(2):297-309. PubMed ID: 4392532
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of slow autooscillations of arterial flow.
    Kenner T; Ono K
    Pflugers Arch; 1972; 331(4):347-56. PubMed ID: 5064568
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug therapy of peripheral arterial blood circulation disorders].
    Bollinger A
    Dtsch Med Wochenschr; 1969 Nov; 94(45):2347-9. PubMed ID: 5346859
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular actions of iproveratril.
    Ross G; Jorgensen CR
    J Pharmacol Exp Ther; 1967 Dec; 158(3):504-9. PubMed ID: 6073232
    [No Abstract]   [Full Text] [Related]  

  • 17. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vascular effect of ephedrine in muscular and mesenteric regions].
    Wepierre J; Cohen Y; Valette G
    Arch Int Pharmacodyn Ther; 1970 May; 185(1):34-46. PubMed ID: 5470022
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthetic peptides with anticoagulant and vasodilating activity.
    Blombäck B; Blombäck M; Olsson P; Svendsen L; Aberg G
    Scand J Clin Lab Invest Suppl; 1969; 107():59-61. PubMed ID: 5375728
    [No Abstract]   [Full Text] [Related]  

  • 20. S-nitrosothiols dilate the mesenteric artery more potently than the femoral artery by a cGMP and L-type calcium channel-dependent mechanism.
    Liu T; Schroeder HJ; Zhang M; Wilson SM; Terry MH; Longo LD; Power GG; Blood AB
    Nitric Oxide; 2016 Aug; 58():20-7. PubMed ID: 27235767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.